Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

agraria pharma gmbh (4021298) - poly(styrol-co-divinylbenzol)sulfonsäure-(x:y)-calciumsalz - granulat zur herstellung einer suspension zum einnehmen - teil 1 - granulat zur herstellung einer suspension zum einnehmen; poly(styrol-co-divinylbenzol)sulfonsäure-(x:y)-calciumsalz (03548) 88,08 gramm

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

sanofi-aventis deutschland gmbh (8030868) - poly(styrol-co-divinylbenzol)sulfonsäure-(x:y)-calciumsalz - pulver - teil 1 - pulver; poly(styrol-co-divinylbenzol)sulfonsäure-(x:y)-calciumsalz (03548) 99,934 gramm

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

curium netherlands b.v. hr-beiname: mallinckrodt pharmaceuicals, curium, curiumpharma, mallinckrodt medical (3199723) - poly(styrol-co-divinylbenzol)sulfonsäure-(x:y)-((81)rb)rubidiumsalz - radionuklidgenerator - teil 1 - radionuklidgenerator; poly(styrol-co-divinylbenzol)sulfonsäure-(x:y)-((81)rb)rubidiumsalz (29143) information nicht vorhanden

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

stada consumer health deutschland gmbh (8151247) - poly(o-2-hydroxyethyl)rutosid - hartkapsel - teil 1 - hartkapsel; poly(o-2-hydroxyethyl)rutosid (02860) 300 milligramm

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

stada consumer health deutschland gmbh (8151247) - poly(o-2-hydroxyethyl)rutosid - filmtablette - teil 1 - filmtablette; poly(o-2-hydroxyethyl)rutosid (02860) 500 milligramm

İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - polysaccharida haemophili influenzae typus b conjugata cum proteino neisseriae meningitidis b, hepatitidis b viri antigenum adnr, toxoidum pertussis, haemagglutininum filamentosum, pertactinum, fimbriae typ 2 und 3, toxoidum diphtheriae, toxoidum tetani, virus poliomyelitis typus 1 inactivatus (mahoney), virus poliomyelitis typus 2 inactivatus (mef-1), virus poliomyelitis typus 3 inactivatus (saukett) - injektionssuspension - polysaccharida haemophili influenzae typus b conjugata cum proteino neisseriae meningitidis b 53 µg corresp. polysaccharida haemophili influenzae typus b 3 µg et neisseria meningitidis b outer membrane protein complex 50 µg, hepatitidis b viri antigenum adnr 10 µg, toxoidum pertussis 20 µg, haemagglutininum filamentosum 20 µg, pertactinum 3 µg, fimbriae typ 2 und 3 5 µg, toxoidum diphtheriae min. 20 u.i., toxoidum tetani min. 40 u.i., virus poliomyelitis typus 1 inactivatus (mahoney) 40 u., virus poliomyelitis typus 2 inactivatus (mef-1) 8 u., virus poliomyelitis typus 3 inactivatus (saukett) 32 u., aluminium ut aluminii phosphas et aluminii hydroxyphosphas sulfas amorphus, natrii phosphates, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.95 mg, residui: glutaralum, formaldehydum, neomycinum, streptomycinum, polymyxinum b, albuminum seri bovis, aluminii thiocyanas, faecis proteina. - grundimmunisierung und auffrischimpfung bei säuglingen und kleinkindern ab einem alter von 6 wochen bis 4 jahre (vor dem 5. geburtstag) gegen diphtherie, tetanus, pertussis, hepatitis b, poliomyelitis und durch haemophilus influenzae typ b (hib) verursachte invasive krankheiten. - impfstoffe

İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - polysaccharida neisseriae meningitidis c (stamm c11,-o-acetyliert), toxoidum tetani - injektionssuspension - polysaccharida neisseriae meningitidis c (stamm c11, de-o-acetyliert) 10 µg conjugatum cum toxoidum tetani 10-20 µg, aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen meningokokken der serogruppe c, ab dem vollendeten 2. lebensmonat - impfstoffe

İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 22f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 33f conjugata cum proteino corynebacteriae diphtheriae crm 197 - injektionssuspension - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197 4 µg et polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 22f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 33f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg corresp. polysaccharida 32 µg et proteinum corynebacteriae diphtheriae crm 197 ca. 30 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.77 mg, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen pneumokokken-infektionen der serotypen 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 22f, 23f, 33f - impfstoffe

İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 10a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 11a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 12f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 15b conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 22f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 33f conjugata cum proteino corynebacteriae diphtheriae crm 197 - injektionssuspension in einer fertigspritze - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197 4.4 µg, polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 10a conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 11a conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 12f conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 15b conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg, polysaccharida streptococci pneumoniae typu - aktive immunisierung gegen pneumokokken-infektionen der serotypen 1, 3, 4, 5, 6a, 6b, 7f, 8, 9v, 10a, 11a, 12f, 14, 15b, 18c, 19a, 19f, 22f, 23f, 33f - impfstoffe

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

staufen-pharma gmbh & co.kg - tonsillitis-polyarthritis-nosode (pot.-angaben) - flüssige verdünnung zur injektion - tonsillitis-polyarthritis-nosode (pot.-angaben) 1.1ml